News Releases

Date Title and Summary Additional Formats
Toggle Summary HTG Molecular Diagnostics Launches its HTG EdgeSeq PATH Assay
TUCSON, Ariz. , June 28, 2017 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq:HTGM), a provider of instruments, reagents and services for molecular profiling applications, announced that it has launched its new HTG EdgeSeq PATH Assay for sale in the U.S. and Europe .
View HTML
Toggle Summary HTG Molecular Diagnostics Participating in WIN 2017 Symposium
TUCSON, Ariz. , June 26, 2017 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq:HTGM), a provider of instruments, reagents and services for molecular profiling applications, announced its participation in WIN 2017 Symposium, dedicated to Expediting Global Innovation in Precision Cancer
View HTML
Toggle Summary HTG Molecular Diagnostics Expands Its IVD Agreement With Illumina to Increase the Number of Test Kits
TUCSON, Ariz. , June 05, 2017 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq:HTGM), a provider of instruments, reagents and services for molecular profiling applications, announced that it has amended and restated its IVD Test Development and Component Supply Agreement with Illumina
View HTML
Toggle Summary HTG Molecular Diagnostics Reports First Quarter 2017 Results
TUCSON, Ariz. , May 15, 2017 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (NASDAQ:HTGM) (HTG), a provider of instruments, reagents and services for molecular profiling applications, today reported financial results for the three months ended March 31, 2017 .
View HTML
Toggle Summary HTG Molecular Diagnostics Introduces HTG EdgeSeq PATH Assay to Launch in Second Quarter 2017
TUCSON, Ariz. , May 04, 2017 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq:HTGM), a provider of instruments, reagents and services for molecular profiling applications, announced that its new HTG EdgeSeq PATH Assay is expected to be available for research uses by the end of the
View HTML
Toggle Summary HTG Molecular Diagnostics to Hold 2017 First Quarter Results Conference Call on May 15, 2017
TUCSON, Ariz. , May 01, 2017 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq:HTGM), a provider of instruments, reagents, and services for molecular profiling applications, today announced that the Company will release 2017 first quarter results after market close on Monday, May 15,
View HTML
Toggle Summary HTG Molecular Diagnostics and Instituto Valenciano de Oncología Initiate Breast Cancer Recurrence Risk Collaboration
TUCSON, Ariz. , April 24, 2017 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq:HTGM), a provider of instruments, reagents and services for molecular profiling applications, announced that it has entered into a research collaboration agreement with Instituto Valenciano de Oncología
View HTML
Toggle Summary HTG Molecular Diagnostics Transfers Listing to The Nasdaq Capital Market
TUCSON, Ariz. , April 17, 2017 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq:HTGM), a provider of instruments, reagents and services for molecular profiling applications, announced that, on April 12, 2017, the company received formal notice from The NASDAQ Stock Market LLC indicating
View HTML
Toggle Summary HTG Molecular Diagnostics and Centre Léon Bérard Enter Into Molecular Profiling Research Agreement
TUCSON, Ariz. , April 17, 2017 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq:HTGM), a provider of instruments, reagents, and services for molecular profiling applications, announced that it has entered into a research agreement with Centre Léon Bérard, which provides the framework
View HTML
Toggle Summary HTG Molecular Diagnostics and Daiichi Sankyo Complete Master Services Agreement
TUCSON, Ariz. , April 17, 2017 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq:HTGM), a provider of instruments, reagents and services for molecular profiling applications, announced that it has entered into a master services agreement with Daiichi Sankyo Company, Limited ( Daiichi
View HTML